CCL Protects
Pharmaceutical and life science companies spend an absorbent amount of money in research and development to bring their medicines and brands to market only to be diverted or counterfeited. According to the Organization for Economic Cooperation and Development (OECD), the global counterfeit market is worth approximately $461 Billion dollars or roughly 2.5 % of all global trade.
Developing an effective brand protection strategy will defend against counterfeiting, diversion, obsolesce, and maintain brand integrity. CCL Healthcare has protected brands for decades with custom brand security strategies and security solutions. These systems protect the integrity of brands and defend against grey market activities.
CCL is the market leader in brand protection offering a wide range of options that included Overt, Covert, and Forensics security features all manufactured under a cGMP process with a specialization in Track and Trace Serialization. Our customers can be assured that CCL Protects!
Recent Blog Posts
Using RFID technology, Clinical Systems can now encode NFC (Near Field Communication) eLabels that will enable access to data for clinical trial materials on a smart device.
Our label stocks are specifically designed for use by clinical supply departments and we maintain a large inventory of standard conventional items.
When contracting with Clinical Systems to manage your trial data, you are assured of complete accuracy for your on-label control parameters.
Find Us
Visit our interactive locations map to find any CCL location in the world.
Filter locations by market or region, or do a radius search from a specific zip code.
